04 Mar

Shining light of medtech market- The Sunday Times

HealthBeacon featured in The Sunday Times, an article by Gavin Daly.

HealthBeacon boss Jim Joyce is helping to ease the pain for patients with his ‘smart’ syringe disposal bins

In an unassuming block off the old Naas Road in Dublin’s industrial heartland, Jim Joyce is giving a guided tour of HealthBeacon, his young medtech company. From outside, HealthBeacon HQ looks like any other building in the area; inside there is a 3D printer in the corner, artificial grass on the floor, and hundreds of the company’s hi-tech devices lie stacked for shipping.

The place is painted duck egg green, so the feeling is like being inside one of HealthBeacon’s “smart” syringe disposal bins, says Joyce, an energetic American who is 15 years in Ireland. He introduces his staff by name and gets them to explain their roles, from design to quality assurance, testing to data analysis.

To read the full article please visit The Times website.

11 Feb

HealthBeacon at HIMSS

HealthBeacon Exec, Andrea Rangel today will participate at the HIMSS conference in Orlando, Florida. In addition to her role with HealthBeacon, Andrea serves as an executive director for ABCIS in São Paulo and will participate in this conference that gathers healthcare leaders from around the world to discover new ways to utilize innovative information and technology to advance health transformation.

Reach out to HealthBeacon today to schedule a meeting with Andrea Rangel at the HIMSS conference in Orlando, Florida.  Andrea@healthbeacon.com

09 Jan

Dublin medtech HealthBeacon raises $12m in a Series A round

With funding and FDA clearance under its belt, this Dublin tech start-up has plans to help patients stick to their medication schedule.

(Dublin, Ireland; San Francisco, CA – January 8th, 2019) Dublin and Boston based digital health company, HealthBeacon announces the completion of its Series A investment round of $12M, bringing total funding to date into the company of $15M. The announcement was made in San Francisco, CA at the JP Morgan Chase Biotech Showcase. The funding comes on the back of rapid global expansion of its FDA cleared HealthBeacon Smart Sharps Technology. 

 The funding from this Series A will be used to launch its Smart Sharps System into the USA and to develop out their portfolio of medical adherence tools for high value medications. The addressable market for injectable medications has reached nearly $50 billion. As of today, HealthBeacon operates in 10 markets and has tracked more than 200,000 home based injections making it one of the largest global deployments of a medical adherence device. Today HealthBeacon employs over 30 people and plans to double the team over the next 18 months.

 The smart sharps bin system by HealthBeacon has made it easier for patients, using injectable medications, to stay on track with their treatment schedule. This has resulted in improved patient medication adherence and driving patient care. In December, they were awarded eHealth Innovation of the Year, by the MedTech Association of Ireland. 

Doug Veale, Professor of Rheumatology, St Vincent’s Hospital Ireland “I’ve been using the HealthBeacon for over two years and their Smart Sharps Bin has had a profound impact on how patients manage their treatment. I know with confidence as to whether my patients are adhering to their treatment strategy.” 

The round was organized by HealthBeacon and Cantor Fitzgerald and led by Oyster Capital and Elkstone Partners, the investment syndicate included Quorndon Capital and Cantor Fitzgerald’s Private Client Group. Previous investors in HealthBeacon include Enterprise Ireland, BVP and a range of Angel Investors. 

Liam Kiely, Director, Cantor Fitzgerald said “We are delighted to have worked with HealthBeacon in putting this $12m Series A round together. Cantor has a major focus on Life Sciences and on Digital Health, and we have every confidence that CEO & co-founder Mr. Jim Joyce has created a true sector leader in HealthBeacon.”

This fundraise was covered by the Silicon Republic and NewsTalk Business Breakfast.

 

20 Dec

HealthBeacon Presents at JP Morgan Digital Medicine and Medtech Showcase

Digital Health company, HealthBeacon, will present for the third time at the 11thAnnual JP Morgan Conference in San Francisco, CA. HealthBeacon CEO, Jim Joyce will present at the Digital Medicine and Medtech Showcase to the biggest names in medical technology. The conference takes place on January 7th– 10that the Parc 55 San Francisco hotel.

HealthBeacon’s presentation time and venue:

Digital Medicine & Medtech Showcase on Tuesday, January 8th , 2018 at the hotel Parc 55 San Francisco at 1:30 pm (PST) – Powell – I (Level 3).

Parc 55 San Francisco – Union Square

55 Cyril Magnin Street, 3rd Floor

San Francisco, CA 94102

About HealthBeacon

HealthBeacon is a Digital Health company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

07 Dec

HealthBeacon Wins eHealth Innovation of the Year

Digital Therapeutic company, HealthBeacon Wins eHealth Innovation of the Year at the Irish Medtech Awards.

HealthBeacon was honoured last night as the eHealth Innovation of the Year at the Irish MedTech Awards. This award is to recognise the integration of ICT in the world of healthcare and rewards the best eHealth/ mHealth solutions produced by the eHealth sector. This award was presented by John Shiel , Senior Development Advisor, Life Sciences Dept, Enterprise Ireland and was received by Kieran Daly, CTO and Joyce Power, Quality Manager.

This award caps a successful 2018 for HealthBeacon that includes achieving FDA clearance, a doubling of markets served, as well as multiple industry awards in Europe and North America.

The evening’s winners were revealed at a black tie gala evening where the best of Ireland’s medtech industry were recognized and celebrated in front of hundreds of senior executives.

In addition, HealthBeacon was invited to attend the two-day Medtech Rising: CEO Conference and Awards, as well as, an opportunity to host a stand at Medtech Rising which is attended by 500 professionals.

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

27 Nov

Vodafone teams with HealthBeacon for patient medication tool

Device developed by digital therapeutics company reminds patients about injections

Vodafone Ireland has teamed up with Irish digital therapeutics company HealthBeacon to provide internet of things (IoT) connectivity for the company’s new smart health product.

HealthBeacon, which is headquartered in Dublin, develops smart tools for managing medication. Its latest product helps to remind patients to inject their medications at home. The device can be programmed with a patient’s medication schedule, and will remind them to take it at the correct times.

Vodafone IoT connectivity will connect the devices and facilitate the transfer of data. “This enables HealthBeacon to streamline our expansion and launch new countries quickly,” said Kieran Daly, HealthBeacon co-founder chief technical officer. “This global partnership will serve patients all over the world and ensure seamless connectivity for both our current and next-generation devices.”

“Remote patient monitoring is one element that empowers people to manage their conditions and helps them to live more independently,” said Debbie Power, Vodafone Ireland’s IoT country manager. “Our next-generation network means we are at the forefront of ensuring healthcare is securely connected now and into the future.”

Featured in:

Irish Times: https://www.irishtimes.com/business/technology/vodafone-teams-with-healthbeacon-for-patient-medication-tool-1.3711371

Silicon Republic: https://www.siliconrepublic.com/machines/healthbeacon-vodafone-medtech-iot-roll-out

14 Nov

HealthBeacon signs agreement with Canada’s leading patient support provider, Innomar Strategies

HealthBeacon, partners with Innomar Strategies, to bring its smart sharps bin offering to Canada.

(DUBLIN, IE., TORONTO, ON. –November 14th, 2018) HealthBeacon announced today their partnership with Innomar Strategies to provide the HealthBeacon smart sharps bin and digital therapeutic platform to Canadian patients across the country.

HealthBeacon is a Dublin headquartered, digital therapeutic company that produces a smart sharps bin to track and drive medication adherence. Following their recent FDA clearance in the US, HealthBeacon has begun investing resources in the North American markets of the United States and Canada. Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market, helping patients navigate the complicated Canadian healthcare system, and providing support for their injections and infusions.

“We have seen great patient engagement with the HealthBeacon tool in Ireland. It has been instrumental in aiding us in identifying patients that need assistance, and helping drive adherence to their medication. I’m delighted to see they are making HealthBeacon available in Canada.” – Dr. Trevor Duffy, Rheumatologist

HealthBeacon began operations in Canada with the opening of their Montreal office in December 2016. HealthBeacon CEO, Jim Joyce commented, The Canadian market is a large market, both geographically and in terms of patients who could benefit from our technology. The signing of this partnership is a major milestone in making our technology accessible to the Canadian market.

As an industry leader, Innomar deeply understands the patient journey.  A core focus is delivering best-in-class care and education through patient services to monitor adherence and ensure optimal outcomes.

“We look forward to partnering with HealthBeacon as they move into the Canadian market.  Our focus is on patient care, and having a tool to track and facilitate medication adherence brings value to patient care across Canada,” says Amar Pabla, Vice President Nursing, Clinics and Pharmacovigilance.

“HealthBeacon are a fantastic example of Irish innovation. This partnership is testimony to the deepening links between Irish and Canadian healthcare. As the government agency driving the growth of Irish businesses internationally, we at Enterprise Ireland look forward to seeing HealthBeacon support Innomar Strategies in its mission to advance patient support across Canada.” – Neil Cooney, Country Manager Canada, Enterprise Ireland

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. The HealthBeacon is a smart sharps bin for patients who self-inject medications at home. It is digitally connected and programmed with a patient’s personal medication schedule, and uses customized reminders to help them start and stay on track with medication. The company is headquartered in Dublin, Ireland and has offices in the US and in Canada. Learn more at www.healthbeacon.com

About Innomar Strategies

Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment tobest-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes. Visit us at www.innomarstrategies.com.

31 Oct

HealthBeacon Builds Presence in Asia

HealthBeacon started off in Ireland piloting its technology with the local Irish divisions of pharmaceutical giants. These same great clients networked us into their global organisation which led to deployment of our HealthBeacon Medication Management technology across 10 Countries: USA, Canada, across the EU, South Africa, Baltics, Brazil, Israel and South Africa. We had to develop global organisational muscles early in our life, our clients made it a prerequisite. Now we are heading to Asia!

We will be featured on two panels at large Digital Health events in both Mumbai and Singapore.

The first will be a global gathering for HealthXL presented by Abbott and featuring panelists and speakers that include Arun Kumar, Head of South Asia for Bayer and Dr Arvind Sivaramakrishnan, Chief Information Officer at Apollo Hospitals

The second event is a panel about Digitising Patient Care featuring Jim Joyce, Everett Leonidas from Aviva Ventures which will be moderated by Susanna Hasenoehrl of Joice Nutrition and hosted by SG Innovate in Singapore.

In collaboration with these two great organisations, HealthXL and SG Innovate, we will begin  introducing ourselves and our technology into the Singapore, Australian and Indian markets. These three markets will become our first wave of Asia-Pac HealthBeacon deployments.

Operating a young technology company across 10 countries from our two office locations,  Dublin and Boston required us to leverage scaling technology platforms, find excellent local partners, build scalable roll-out processes that are all driven by a team that thinks globally.

 

HealthXL Global Gathering Mumbai

Date/Venue: 1st November 2018, 9:00am- 4:00pm

Bandra Kurla Complex Mumbai

Topics: 

  • Patient Centricity
  • Non-Communicable DiseaseDigital
  • Health Investments in India
  • Big Data to Improve Patient Outcomes

 

 

 

Digitising Patient Care- SG Innovate

Date/ Venue: 8th November 2018, 5:00pm- 7:00pm

32 Carpenter Street, Singapore 059911

In the midst of a patient data revolution, this panel will discuss the importance of caring for and facilitating patient data in a way that makes sense. Medtech and digital therapeutics are increasingly focused on patient centricity and care. Our leading experts will be focused on providing a vision for the future of patient care in a digital world.

 

 

25 Oct

HealthBeacon Sponsors Ireland’s Cancer Fund for Children

HealthBeacon will be supporting the Cancer Fund for Children as the “Speakeasy” Sponsor at this years’ Gala Ball. The Gala Ball is part of a 5-year program that aims to raise €1m for the Cancer Fund for Children. They are in large part supported by Ireland’s Digital Economy with its inaugural 2017 Gala Ball raising more than €137,000. The goal is to build a brand new therapeutic centre for children diagnosed with cancer, and their families, in Ireland.

Cancer Fund for Children has been supporting families for over forty years. They offer practical, emotional and financial help and also include stress-relieving, nurturing breaks at their therapeutic centre Daisy Lodge in County Down. Unfortunately, the overwhelming need has the centre operating at full capacity and created a long wait list for families.

This fundraising program will bring Daisy Lodge Connacht to the west of Ireland. This worthy project is supported by prominent Irish citizens such as professional golfer Rory McIlroy and will be attended by over 300 people including Paul Harrington, Bobby Kerr, Holly Carpenter and Eddie Irvine.

“HealthBeacon is delighted to be sponsoring this great event and worthy cause. The Cancer Fund for Children has ambitious plans for their new therapeutic centre in Mayo. This site will be entirely dedicated to support children and their families that have been diagnosed with cancer.” Jim Joyce, CEO HealthBeacon

For more information on the project, please see https://cancerfundforchildren.com/event/great-gatsby-gala-ball/

24 Oct

HealthBeacon attends Johnson & Johnson, JLABS CEO Summit

HealthBeacon are delighted to attend the 2nd annual JLABs CEO Summit in sunny La Jolla, San Diego. 

The event has gathered partners of Johnson & Johnson’s, JLABs group for two days of networking and information exchange as well as talks and panel discussions with industry leaders. 

HealthBeacon has been part of the global JLABs network after being chosen as the winner of the Johnson & Johnson Innovation, JLABS and Janssen Supply Chain Group, LLC (JSC) Patient Adherence QuickFire Challenge earlier this year.

Since winning the QuickFire Challenge, HealthBeacon has achieved FDA clearance for it’s smart sharps bin and launched in an additional four markets including the U.S. so there is a lot to catch up on with old friends and new at the event. 

This coupled with the growth of our product portfolio and data analytics platform offers a clear point of intersection within the JLABs ecosystem.

Having completed day one of the event which was focussed on JPAL & Investor Partnering we are excited to partake in the CEO Summit main program which began tonight featuring talks from J&J executives, JLABS CEOs, investors and industry leaders, and continues on Wednesday 24th.

 

© 2015 Health Beacon - Privacy Policy - Website by Medusa